Most Read Articles
01 Dec 2019
Macrolide antibiotics are derived from the Streptomycesspecies. These contain either 14-membered (erythromycin [ERM],clarithromycin [CAM], roxithromycin [RXM]), 15-membered(azithromycin [AZM]) or 16-membered (spiramycin, josamycin,midecamycin) macrocyclic lactone rings. They inhibit proteinsynthesis by reversibly binding to the 23S ribosomal RNA (rRNA)in the 50s subunit of the bacterial ribosome. Traditionally,macrolides are used as first-line agents in respiratory, skin,soft tissue, and urogenital infections, and they are also activeagainst gram-positive cocci and atypical pathogens.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
Jairia Dela Cruz, 4 days ago
Nonsmall cell lung cancer (NSCLC) patients harbouring sensitive EGFR mutations may fare well with the third-generation tyrosine kinase inhibitor osimertinib as an upfront therapy, with the results of a network meta-analysis showing that the drug tops other currently available options in terms of progression-free survival and tolerability.
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.

Global sepsis incidence hits 48.9M, deaths at 11M

Elvira Manzano
05 Feb 2020

The global incident cases of sepsis were recorded at 48.9 million in 2017, with 11 million related deaths worldwide, according to the IHME* Sepsis study which analysed data from the comprehensive Global Burden of Disease 2017 study.

“These estimates were twice the figures we had previously assumed, likely because the study included data from low-and middle-income countries where sepsis incidence and mortality are considerably higher and for which data were previously underrepresented,” said co-author Professor Konrad Reinhart from Jena University Hospital in Jena, Germany and  president of the Global Sepsis Alliance at the recent CCR20 Meeting. “Sepsis incidence and deaths varied across the region, with the highest burden in sub-Saharan Africa, Oceania, South Asia, East Asia, and Southeast Asia.” [Lancet 2020;395:200-211]

Of note, the difference between current and previous estimates was particularly striking in children, where more than half of cases occurred in this population, many of them newborns, he added.

Data on the global incidence of sepsis and related mortality were limited prior to this analysis. Most studies were only restricted to patients admitted to the hospitals and excluded children. As sepsis is a syndrome caused by an underlying infection, it is not part of the standard Global Burden of Diseases, Injuries, and Risk Factors Study estimates. Dr Kristina Rudd from the University of Pittsburgh in Pittsburgh, Pennsylvania, US and her team sought to estimate the incidence of sepsis and mortality using data from 109 million individual death records spanning from 1990 to 2017.

In 1990, there were 60.2 million estimated cases of sepsis. This was down to 48.9 million in 2017, a reduction of 18.8 percent. Of all incident cases in 2017, 33.1 million occurred in those with an underlying infectious cause of health loss, 15.8 million in those with underlying injuries or noncommunicable disease. The incidence of age-standardized sepsis also dropped by 37 percent, so was mortality by 52.8 percent.

“We now have a new and robust evidence of the burden of sepsis worldwide,” Rudd said at CCR20. This finding has several key implications for health policy makers, clinicians, and researchers.  “First, the global burden of sepsis is larger than previously appreciated and requires urgent attention. Second, there is substantial variation in incidence and mortality according to Healthcare Access and Quality Index , with the highest burden in locations that are least equipped to prevent, identify, or treat sepsis. Third, more robust infection-prevention measures should be assessed and implemented in areas with the highest incidence of sepsis and among populations wherein sepsis will have the greatest impact, for example, neonates.”

Sepsis is the body’s overwhelming and life-threatening response to infection that can lead to tissue damage, organ failure, and death. “Our results highlight the need for greater prevention and treatment of sepsis, particularly in areas of the world with the lowest sociodemographic index,” said the authors.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2019
Macrolide antibiotics are derived from the Streptomycesspecies. These contain either 14-membered (erythromycin [ERM],clarithromycin [CAM], roxithromycin [RXM]), 15-membered(azithromycin [AZM]) or 16-membered (spiramycin, josamycin,midecamycin) macrocyclic lactone rings. They inhibit proteinsynthesis by reversibly binding to the 23S ribosomal RNA (rRNA)in the 50s subunit of the bacterial ribosome. Traditionally,macrolides are used as first-line agents in respiratory, skin,soft tissue, and urogenital infections, and they are also activeagainst gram-positive cocci and atypical pathogens.
29 Nov 2019
Metformin Extended Release 500 mg,750 mg, and 1000 mg
Jairia Dela Cruz, 4 days ago
Nonsmall cell lung cancer (NSCLC) patients harbouring sensitive EGFR mutations may fare well with the third-generation tyrosine kinase inhibitor osimertinib as an upfront therapy, with the results of a network meta-analysis showing that the drug tops other currently available options in terms of progression-free survival and tolerability.
01 Dec 2019
Pneumonia is a common infection– affecting around 3,200 people inSingapore in 2016 – making it the thirdmost common cause of hospitalisation inthe country. Its common complications,especially with delayed or inappropriatetreatment, include bacteraemia andseptic shock, lung abscesses, pleuraleffusions, empyema, pleurisy, respiratoryfailure and renal failure.